Brilliant Pharmaceuticals Overview
- Year Founded
-
1995
- Status
-
Private
- Employees
-
3,322
- Latest Deal Type
-
IPO
- (Cancelled)
- Investors
-
4
Brilliant Pharmaceuticals General Information
Description
Researcher and developer of new drugs, generic drugs, and traditional Chinese medicines (TCM). The company's products include anti-infectives and drugs targeting multiple biological systems including cardiovascular, respiratory, urinary, and more aimed to help regulate patients' bodies, helping them live a healthy and energetic life.
Contact Information
Website
www.btyy.comCorporate Office
- No.1166, Konggang 4th Road
- Southwest Airport Economic Development Zone, Shuangliu District
- Chengdu, Sichuan
- China
Corporate Office
- No.1166, Konggang 4th Road
- Southwest Airport Economic Development Zone, Shuangliu District
- Chengdu, Sichuan
- China
Brilliant Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 13-Jan-2022 | Cancelled | Generating Revenue | |||
| 6. Secondary Transaction - Private | 27-Jun-2019 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 29-Mar-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 09-Jan-2019 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 05-Dec-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 20-Sep-2018 | $7.3M | $7.3M | Completed | Generating Revenue | |
| 1. Later Stage VC | Completed | Generating Revenue |
Brilliant Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Brilliant Pharmaceuticals Patents
Brilliant Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026233290-A1 | Rnai composition and use thereof | Pending | 07-May-2025 | ||
| WO-2026228529-A1 | New crystal form of compound containing bis(azanylylidene) sulfonyl structure | Pending | 27-Apr-2025 | ||
| WO-2026219263-A1 | Modified double-stranded oligonucleotide and use thereof | Pending | 15-Apr-2025 | ||
| WO-2026158295-A1 | Hbv-targeting small nucleic acid | Pending | 21-Jan-2025 | ||
| WO-2026139009-A1 | Rnai composition and use thereof | Pending | 27-Dec-2024 |
Brilliant Pharmaceuticals Signals
Brilliant Pharmaceuticals Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Juxin Development Equity Investment Fund Management | PE/Buyout | Minority | ||
| Jundu Investment | Growth/Expansion | Minority | ||
| Beijing Guosheng Asset Management | Growth/Expansion | Minority | ||
| Daoyuan Capital | Venture Capital | Minority |
Brilliant Pharmaceuticals Acquisitions (1)
Brilliant Pharmaceuticals’s most recent deal was a Merger/Acquisition with Sanfengyou. The deal was made on 26-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanfengyou | 26-Jul-2022 | Merger/Acquisition | Pharmaceuticals |
Brilliant Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sanfengyou | Haikou, China | 2005 |
Brilliant Pharmaceuticals FAQs
-
When was Brilliant Pharmaceuticals founded?
Brilliant Pharmaceuticals was founded in 1995.
-
Where is Brilliant Pharmaceuticals headquartered?
Brilliant Pharmaceuticals is headquartered in Chengdu, China.
-
What is the size of Brilliant Pharmaceuticals?
Brilliant Pharmaceuticals has 3,322 total employees.
-
What industry is Brilliant Pharmaceuticals in?
Brilliant Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Brilliant Pharmaceuticals a private or public company?
Brilliant Pharmaceuticals is a Private company.
-
What is Brilliant Pharmaceuticals’s current revenue?
The current revenue for Brilliant Pharmaceuticals is .
-
How much funding has Brilliant Pharmaceuticals raised over time?
Brilliant Pharmaceuticals has raised $7.3M.
-
Who are Brilliant Pharmaceuticals’s investors?
Juxin Development Equity Investment Fund Management, Jundu Investment, Beijing Guosheng Asset Management, and Daoyuan Capital have invested in Brilliant Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process